Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ezio Degli Esposti
Clinical Outcomes and Health Care Costs Combining Metformin With Sitagliptin or Sulphonylureas or Thiazolidinediones in Uncontrolled Type 2 Diabetes Patients
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Referral to Sub-Specialists: Who Have the Most to Gain From Early Specialist Intervention Among Patients With Markers of Renal Disease?
Italian Journal of Medicine
Medicine
Related publications
Health Care Resource Use and Costs in Patients With Type 2 Diabetes Mellitus After Treatment Initiation With Saxagliptin or Sitagliptin
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
54-Or: Oral Semaglutide vs. Empagliflozin Added on to Metformin Monotherapy in Uncontrolled Type 2 Diabetes: PIONEER 2
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
Health Care and Health Status and Outcomes for Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Health Care Costs Associated With Incident Complications in Patients With Type 2 Diabetes in Germany
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Preventing, Delaying, or Masking Type 2 Diabetes With Metformin in the Diabetes Prevention Program?
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Cost-Utility Analysis of Liraglutide Compared With Sulphonylurea or Sitagliptin, All as Add-On to Metformin Monotherapy in Type 2 Diabetes Mellitus
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Sitagliptin Improves Albuminuria in Patients With Type 2 Diabetes Mellitus
Journal of Diabetes Investigation
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients With Type 2 Diabetes Not Controlled With Metformin
Internal Medicine
Internal Medicine
Medicine
Combining Sitagliptin/Metformin With a Functional Fiber Delays Diabetes Progression in Zucker Rats
Journal of Endocrinology
Endocrinology
Metabolism
Diabetes